Top 5 Stocks To Watch For 2019

Shares of large companies, as measured by Standard & Poor’s 500-stock index, have had a great run since bottoming on March 9, 2009. Despite losing 19.3% over the past year, the index has since returned 241.3%, or 19.2% annualized. Over that same stretch, Barclays U.S. Aggregate Bond index has returned a not-too-shabby 4.5% annualized. But here’s the thing: Virtually everything you’ve done over the past three-to-five years to diversify beyond blue-chip U.S. stocks and high-quality bonds has hurt your portfolio’s performance.

See Also: How to Invest in Emerging Markets in 2016

I’ve made my share of mistakes. Perhaps the most egregious has been my steadfast bullishness toward emerging-markets stocks. And how have they performed? Over the past five years, the MSCI Emerging Markets stock index has lost an annualized 4.4%, compared with an annualized gain of 10.9% for the S&P 500. That’s a gap of 15.3 percentage points per year, on average. Yikes! (All returns in this article are through March 9.)

Top 5 Stocks To Watch For 2019: First Financial Corporation Indiana(THFF)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Get a free copy of the Zacks research report on First Financial (THFF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Logan Wallace]

    GSA Capital Partners LLP decreased its holdings in shares of First Financial Co. Indiana (NASDAQ:THFF) by 12.6% in the 1st quarter, Holdings Channel reports. The fund owned 20,900 shares of the bank’s stock after selling 3,000 shares during the quarter. GSA Capital Partners LLP’s holdings in First Financial Co. Indiana were worth $869,000 at the end of the most recent quarter.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on First Financial (THFF)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 5 Stocks To Watch For 2019: Halliburton Company(HAL)

Advisors’ Opinion:

  • [By Logan Wallace]

    Aristotle Capital Management LLC lifted its stake in shares of Halliburton (NYSE:HAL) by 4.9% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,886,928 shares of the oilfield services company’s stock after purchasing an additional 230,408 shares during the quarter. Aristotle Capital Management LLC owned 0.56% of Halliburton worth $229,392,000 as of its most recent SEC filing.

  • [By Jason Hall]

    In this week’s episode of Industry Focus: Energy, host Nick Sciple and Motley Fool contributor Jason Hall explain. Find out how the industry works, the biggest threats and opportunities in the industry today, and what long-term investors should know before buying in. Also, the hosts take a deep dive on two of the biggest companies in the space, Schlumberger (NYSE:SLB) and Halliburton (NYSE:HAL). Learn what differentiates the two, which one has performed better lately, and, of course, which company looks like the better long-term buy.

  • [By WWW.GURUFOCUS.COM]

    For the details of Packer & Co Ltd’s stock buys and sells, go to www.gurufocus.com/StockBuy.php?GuruName=Packer+%26+Co+Ltd

    These are the top 5 holdings of Packer & Co LtdBall Corp (BLL) – 625,005 shares, 7.52% of the total portfolio. Hess Corp (HES) – 2,039,400 shares, 6.78% of the total portfolio. Anadarko Petroleum Corp (APC) – 1,432,600 shares, 6.35% of the total portfolio. Shares added by 14.37%Citigroup Inc (C) – 604,500 shares, 6.34% of the total portfolio. Shares reduced by 11.04%General Electric Co (GE) – 1,118,800 shares, 5.98% o

Top 5 Stocks To Watch For 2019: Roche Holding AG (RHHBY)

Advisors’ Opinion:

  • [By Keith Speights]

    Healthcare giant Roche (NASDAQOTH:RHHBY) is also a key player in the liquid-biopsy world, thanks to its acquisition last year of Foundation Medicine. Roche already owned more than 50% of Foundation and grabbed the rest of the fast-rising diagnostics company as soon as it could.

  • [By ]

    Syndax is riding on the power of two lead molecules (entinostat and SNDX-6352) to power an enriched pipeline that can deliver hope to patients afflicted by various deadly cancers. If the reporting for the Phase 3 (E2112) within months turns out positive as we prognosticated, the share can appreciate by approximately one fold. Given the various partnership with Merck and Roche (OTCQX:RHHBY) for the co-development of entinostat with their flagship molecules (Keytruda, Tecentriq, and Bavencio), the company can get acquired if it demonstrates the strong clinical outcomes.

  • [By SEEKINGALPHA.COM]

    News: LUPNY announced that the FDA has granted approval to their generic form of Roche’s (OTCQX:RHHBY) oseltamvir (branded Tamiflu). It intends to begin selling in short order.

  • [By Ethan Ryder]

    Shares of Roche Holding AG (OTCMKTS:RHHBY) have been assigned a consensus rating of “Hold” from the thirteen brokerages that are covering the stock, Marketbeat reports. Four equities research analysts have rated the stock with a sell recommendation, six have given a hold recommendation and three have issued a buy recommendation on the company. The average 12-month price target among brokerages that have covered the stock in the last year is $38.00.

  • [By SEEKINGALPHA.COM]

    Things aren’t as dire at Roche (OTCQX:RHHBY) as the market may have you believe, but the reality is the company needs to deliver strong clinical data from multiple upcoming late-stage trials. Generics are coming after key drugs that contribute close to 40% of the company’s total revenue, and investors need a reason to believe again that Roche can continue to generate worthwhile growth as these veteran contributors start to diminish.

  • [By Todd Campbell]

    Reports are that Roche Holdings (NASDAQOTH:RHHBY) may be working on an acquisition of Tesaro; however, Roche and Tesaro have yet to confirm that they’re in talks.

Top 5 Stocks To Watch For 2019: Packaging Corporation of America(PKG)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Packaging Corp Of America (NYSE:PKG) has been given an average rating of “Hold” by the eleven analysts that are currently covering the stock, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation, six have assigned a hold recommendation and four have given a buy recommendation to the company. The average 1-year target price among brokerages that have updated their coverage on the stock in the last year is $128.67.

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Packaging Corp Of America (PKG)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Ethan Ryder]

    Sonoco (NYSE: SON) and Packaging Co. of America (NYSE:PKG) are both industrial products companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, profitability, risk, dividends, institutional ownership and valuation.

  • [By Ethan Ryder]

    People s United Financial Inc. lowered its position in shares of Packaging Corp Of America (NYSE:PKG) by 42.2% in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 10,941 shares of the industrial products company’s stock after selling 7,973 shares during the quarter. People s United Financial Inc.’s holdings in Packaging Corp Of America were worth $1,223,000 as of its most recent filing with the SEC.

Top 5 Stocks To Watch For 2019: Innodata Inc.(INOD)

Advisors’ Opinion:

  • [By Logan Wallace]

    Luzich Partners LLC lifted its stake in shares of Innodata Inc (NASDAQ:INOD) by 4.9% during the 1st quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 1,316,550 shares of the technology company’s stock after acquiring an additional 61,944 shares during the period. Innodata accounts for approximately 1.5% of Luzich Partners LLC’s portfolio, making the stock its 12th biggest position. Luzich Partners LLC owned about 5.09% of Innodata worth $1,514,000 at the end of the most recent reporting period.

  • [By Stephan Byrd]

    Media coverage about Innodata (NASDAQ:INOD) has trended somewhat positive this week, according to Accern Sentiment Analysis. The research firm scores the sentiment of press coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Innodata earned a media sentiment score of 0.10 on Accern’s scale. Accern also gave news articles about the technology company an impact score of 47.3485759085159 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

  • [By Stephan Byrd]

    Innodata (NASDAQ:INOD) will be releasing its Q1 2018 earnings data before the market opens on Tuesday, May 8th.

    Innodata (NASDAQ:INOD) last announced its earnings results on Thursday, March 8th. The technology company reported ($0.02) earnings per share (EPS) for the quarter. The business had revenue of $15.66 million for the quarter. Innodata had a negative return on equity of 10.94% and a negative net margin of 8.30%.

Leave a Reply

Your email address will not be published. Required fields are marked *